The U.S. FDA is publicly recruiting members for its Tobacco Products Scientific Advisory Committee, with nominations accepted from both individuals and organizations

Key points:

·Member Recruitment: The FDA is openly soliciting members for the Tobacco Products Scientific Advisory Committee, covering experts from various medical and scientific fields. 

·Nomination Deadline: The deadline for nominations is August 25, 2025, and can be submitted electronically or by mail. 

·Term Arrangement: New members will serve for a maximum of four years, starting from February 1, 2026. 

·Committee Responsibilities: TPSAC is responsible for reviewing the safety, dependence, and health issues of tobacco products, providing professional advice to the FDA.

According to an FDA announcement on July 30th, the FDA is seeking nominations for voting members to join the Tobacco Products Scientific Advisory Committee (TPSAC) by August 25, 2025. Individuals can self-nominate or be nominated by any interested person or organization.

Specifically, the TPSAC is looking for five vacant members, who should be doctors, dentists, scientists, or healthcare professionals specializing in oncology, pulmonology, cardiology, toxicology, pharmacology, engineering, or other related fields. Among these five vacancies are one for a representative of the general public and one for a federal, state, or local government employee. The selected members will be invited to serve for a maximum of four years, with their term beginning on February 1, 2026, after the current members' terms end.

All nominations should be submitted electronically through the FDA Advisory Nomination Portal, or by email to the committee's oversight and management staff. Nominations received after August 25, 2025 will be considered for future committee vacancies.

The Tobacco Products Scientific Advisory Committee (TPSAC) advises the FDA on matters related to tobacco product regulation, such as applications for modified risk tobacco products submitted by manufacturers. This committee reviews and evaluates the safety, addictiveness, and health issues related to tobacco products, and provides appropriate advice, information, and recommendations to the FDA Commissioner.